Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
ethics and corporate governance
social corporate responsibility
social corporate responsibility
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: ethics and corporate governance
Merck did not act responsible when the issues arose with Vioxx. Corporate Sociel responsibility is defined by Investopedia as,” CSR may also be referred to as "corporate citizenship" and can involve incurring short-term costs that do not provide an immediate financial benefit to the company, but instead promote positive social and environmental change” ("Corporate Social Responsibility Definition | Investopedia"). During a COMMITTEE ON GOVERNMENT REFORM Dr.Grham testified that,” On the other hand, the FDA seems to be uninterested in the fact that--and part of the reason we are here today, Dr. Graham, who did the biggest study on Vioxx, testified before the Senate Finance Committee that he believed that Vioxx contributed to as many as 139,000 …show more content…
David Graham "between 89,000 and 139,000 people had been seriously affected by the drug (Vioxx) ( Jack, 2005)." Merck now faces costly lawsuits, angry investors and falling profits ( Simmons and Stipp, 2004; Nossiter, 2005). As of mid-August of 2005, more than 4,200 civil suits have been filed against the company for Vioxx ("Friday August 19th, 2005 | Houston Public Media"). Many states field charges against Merck including Texas and New Jersey, which Merck’s home office is located in New Jersey. Many have presented Internal Merk documents stating that, “some of the company 's scientists were worried about heightened heart attack risks long before Vioxx was withdrawn from the market” ("Archives | The Star …show more content…
Profit is important, perhaps though this can be compromised ten fold if the product becomes dangerous to the consumer. Hence the suits that were filed against Merck. The FDA was created by the government to monitor foods and drugs that are released to the citizens of the United States. However, entitities such as the FDA are rather limited to what they can monitor. Therefore, the ethical operations of a company are to disclose the accurate information. Ethically, Merck did recall Vioxx, however, this action was only after many individuals lost their
The painkiller Vioxx was introduced in 1999 by Merck & Co. It has been used by over 20 million Americans since it was put on the market. Vioxx remained on the market for approximately five years without adequate warnings about its risks. In September of 2004, Merck took Vioxx off the market after a study revealed that it doubled the risk of heart attack or stroke for patients that used it for more than 18 months. Although Merck claimed that they had no idea of these possibly lethal side effects, some internal documents imply that they had been aware of the problem for years and had not made moves to change it. Over 300 lawsuits have been filed against Merck, and it is expected that thousands more will arise.
Just like the kid that buys a sugary cereal just because it has Spongebob Squarepants on it, or like the person that goes to Disneyland to have fun but at end of that day, they can buy a churro. Parents also need to take a action in this too, just because you kid gives you a temper tantrum doesn’t mean that you need to buy them the candy they want in order for them to stop crying, and parents should also be informed of the things that their kids are consuming at their schools. Food companies should market or promote the TINY WORDS on the back of their product that informs all of the substances they used to make the product, to the consumer. Just like they would promote their food products to get consumers. Think about these following questions: What will you do to be informed of the chemicals used on the products you and your family consumes? Is it worth buying just because it has your favorite characters, movie, or games on
The FDA was given the authority to approve pharmaceutical products for marketing in the U.S. as a result of the Federal Food, Drug, and Cosmetic Act, passed in 1938 (FDA par 2). In 1960’s, the agency issued final regulations for prescription drug advertising, which stipulated that these ads must not be false or misleading, present a “fair balance” of information describing both the risks and benefits of a drug, include facts that are “material” to the product’s advertised uses, and include a “brief summary” that mentions every risk described in the product’s ...
...pecially with the use of DTC advertising, to such a wide range of afflictions greatly increased their consumer base, but one of them proved to be deadly. In 1999, four years after Lilly sent study results to the U.S. Food and Drug Administration showing Zyprexa didn’t alleviate dementia symptoms in older patients, it began marketing the drug to those very people, according to documents unsealed in insurer suits against the company for overpayment.(Applbaum, 248). Soon after it began to be used in those suffering from dementia, there were studies produces that showed an increase in death rate among elderly patients taking Zyprexa. In January of 2009, Eli Lilly and Company, who produced the drug, ended up settling the lawsuit and agreed to pay $1.415 billion which was one of the biggest corporate settlements in the history of pharmaceutical companies (Applbaum, 237).
There is a debate on whether direct-to-consumer advertising of pharmaceutical drugs is moral. These drug companies believe they are providing consumer awareness for patients potentially suffering illnesses, while critics argue that patients demand particular drugs from their doctor while there might be
Confronted with two failed methodologies, Merck then falsified the test data to guarantee the results it desired. Having achieved the desired efficacy threshold, Merck submitted these fraudulent results to the FDA and European Medicines Agency. Merck attempted to cover up their fraudulent testing actions by destroying evidence of the falsified data and then lying to an FDA investigator. Merck also attempted to bribe the team on the MMRII testing process with financial incentives to cooperate and remain silent about the fraudulent activities and testing taking place. Merck went as far as to threaten Stephen Krahling with jail if he reported fraud to the FDA. Clearly, Merck’s purposes are corrupted and its actions of manipulating science distained its very mission of making the public healthier. Merck is doing the exact opposite of what its company’s objective is to do, it is putting young children and the public’s health at risk, all for the objective of continuous profit, reputation, power, influence, and maintaining its precious license to continue to distribute this vaccine. Thus, Merck’s actions and behaviors are unethical for defrauding the FDA and European Medicines
1) This case provides background on DTC marketing for prescription drugs and also suggests that the use of this type of marketing is somewhat controversial. What ethical issues can you identify that might be of concern to patients, healthcare professionals, and pharmaceutical companies with regard to DTC marketing? Be specific.
FDA, so many people were harmed. Even other countries versions of the FDA approved it which
Marketers operating in the drug industry have to push their products which then raises the ethical questions that surround the profession of medical delivery. Pharmaceutical companies disburse billions of dollars annually to research, develop, and market drugs. Every pharmacy company needs the endorsement of their drugs from physicians and doctors, so they have to ensure that the doctors are well treated. According to the Pew Charitable Trust, the pharmaceutical corporation spent over $27 billion on advertising alone in 2012, with $24 billion of that dedicated to marketing to physicians. (Kessel, 2014) A further survey conducted by Deloitte shows that 35% of the doctors accept some gratuity payment from the pharmacy companies and 16% of the doctors take money to represent the pharmacy company in conferences and health camps. (Kessel, 2014) The Accreditation Council for Continuing Medical Education declares that pharmaceutical and medical equipment companies funded almost one-third of continuing medical education (CME) opportunities for doctors in 2011.( (Barnett, 1989)
The first social problem surrounding the health care system in the United States is the growing problem with pharmaceutical companies. The industry averages a 17% profit margin and it has been booming for decades, but the industry is being heavily led by a core group of companies (Dr. Pratt). “In 1992 the top 10 companies accounted for roughly one-third of global pharmaceutical revenue, after a period of consolidation, by 2001 the top 10 accounted for nearly half.”( Leon-Guerrero, Zentgraf, 172). These companies hold a large majority of the market share and make most of their money off patented drugs. This growing core of companies that are dominating the market are causing more problems rather than solving them. These companies are all about making as much money as they can and it shows through the salaries of the executives of these companies (Dr. Pratt). The pharmaceutical industry should have their number one priority be to the users of their products rather than profit gains.
There are numerous concerns with Publication bias. Research is becoming less innovative and its neutrality is decreasing. Well-conducted studies may be repeated unnecessarily due to higher under-reporting of negative studies. Reviews of published data have become increasingly skewed by this imbalance in reporting. It wastes valuable time, resources, and funding that could be used on other beneficial research. Another concern is that doctors could make health-costly decisions due to overestimation of benefit and underestimation of harm caused by negative results not being published. The famous cover up of anti-inflammatory drug Rofecoxib’s negative effects (Vioxx) is an example of how withholding negative results can hurt patients (Curfman, 2005). Rofecoxib was prescribed to 80 million people. After 5 years, it was revealed that founding company, Merck,...
Since its humble beginning as a small drugstore, Merck has placed a large amount of importance on improving the health and well-being of its customers. As drug patents expire and genetic forms of their top products become available, Merck’s strategy is to do the unexpected; instead of raising the price of their older products in favor of patent protected new drugs, Merck focuses on reducing their cost in order to better compete with their generic counterparts. Additionally, Merck’s plan for growth now encompasses a much more aggressive pursuit of new drugs in their pipeline through extensive research. Merck became the second largest health care company in the world after the merger with Schering-Plough in 2009 and has contributed great discoveries like the first cervical cancer vaccine and great resources like the Merck Manuals which are utilized as a source of information to doctors, scientists and consumers worldwide .
In the business of drug production over the years, there have been astronomical gains in the technology of pharmaceutical drugs. More and more drugs are being made for diseases and viruses each day, and there are many more drugs still undergoing research and testing. These "miracle" drugs are expensive, however, and many Americans cannot afford these prices.
There is an increasing pressure within pharmaceutical markets to reduce prices in line with medical budgets, as well as maintaining patent expirations. Being a global brand means disturbance in the operations when the market fluctuates. There is an internal weakness in the pharmaceutical industry, which includes theft and counterfeiting of drugs, and therefore is a weakness of Johnson & Johnson. While Johnson & Johnson has these specified weaknesses they deal with, there are even more opportunities which gives them an advantage for strengthening their position in the market. They already have the strength of meeting a broader range of customer needs with their products falling under three categories. Expiring patents on brand name drugs lead to an increase in the sales of generic drugs, Johnson & Johnson could capitalize upon this opportunity. With diagnostic markets growing, this positions the company in a good place as well as new medical therapies and findings that align with some of the company’s primary capabilities. Threats the company faces is with product recalls, extreme competition in pharmaceuticals that results usually in the first to enter is generally where success is determined. With technology developments, biotech concepts might possibly move the traditional pharmaceutical methods out of the
The movie went even deeper into the pocket of these corporations. We got to see who is really in the FDA. We soon found out previous CEO’s of food incorporation such as Tyson has taken control of the FDA board (Kenner). As a result, there wasn’t only a question of conflict of interest. Further towards the end of the movie we see how a natural farm works. During which, we are told by the owner of the farm that the FDA attempted to shut them down due to the threat of possible contamination during the gutting process in the farm. Though the farm took action and made an independent study that showed their food was cleaner than the food industry. This is a great example of independence; just because we have one huge company that can do anything it doesn’t mean it more efficient or safer.